DK2010501T3 - Imidazolbaserede forbindelser, sammensætninger omfattende disse og fremgangsmåder for deres anvendelse - Google Patents
Imidazolbaserede forbindelser, sammensætninger omfattende disse og fremgangsmåder for deres anvendelseInfo
- Publication number
- DK2010501T3 DK2010501T3 DK07751414.9T DK07751414T DK2010501T3 DK 2010501 T3 DK2010501 T3 DK 2010501T3 DK 07751414 T DK07751414 T DK 07751414T DK 2010501 T3 DK2010501 T3 DK 2010501T3
- Authority
- DK
- Denmark
- Prior art keywords
- imidazole
- compositions
- methods
- based compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77647306P | 2006-02-24 | 2006-02-24 | |
US81522106P | 2006-06-20 | 2006-06-20 | |
US11/698,253 US7649098B2 (en) | 2006-02-24 | 2007-01-25 | Imidazole-based compounds, compositions comprising them and methods of their use |
PCT/US2007/004648 WO2007100617A2 (en) | 2006-02-24 | 2007-02-21 | Imidazole-based compounds, compositions comprising them and methods of their use |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2010501T3 true DK2010501T3 (da) | 2014-06-30 |
Family
ID=38320192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07751414.9T DK2010501T3 (da) | 2006-02-24 | 2007-02-21 | Imidazolbaserede forbindelser, sammensætninger omfattende disse og fremgangsmåder for deres anvendelse |
Country Status (20)
Country | Link |
---|---|
US (3) | US7649098B2 (da) |
EP (2) | EP2090334B1 (da) |
JP (1) | JP5153655B2 (da) |
KR (1) | KR20080096570A (da) |
AU (1) | AU2007221265B2 (da) |
BR (1) | BRPI0710076A2 (da) |
CA (1) | CA2643021C (da) |
DK (1) | DK2010501T3 (da) |
EA (1) | EA015783B1 (da) |
EC (1) | ECSP088692A (da) |
ES (1) | ES2456673T3 (da) |
IL (1) | IL193297A (da) |
MX (1) | MX2008010772A (da) |
NO (1) | NO20084024L (da) |
NZ (1) | NZ570308A (da) |
PL (1) | PL2010501T3 (da) |
PT (1) | PT2010501E (da) |
SG (1) | SG170024A1 (da) |
WO (1) | WO2007100617A2 (da) |
ZA (1) | ZA200806842B (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005122285A2 (en) | 2004-06-04 | 2005-12-22 | The Board Of Trustees Of The University Of Illinois | Methods and devices for fabricating and assembling printable semiconductor elements |
TW200848029A (en) | 2007-03-01 | 2008-12-16 | Lexicon Pharmaceuticals Inc | Heterocyclic compounds, compositions comprising them and methods of their use |
AR065980A1 (es) * | 2007-04-12 | 2009-07-15 | Lexicon Pharmaceuticals Inc | Metodos para preparar compuestos basados en imidazol |
TWI412362B (zh) * | 2007-04-12 | 2013-10-21 | Lexicon Pharmaceuticals Inc | (e)-1-(4-((1r,2s,3r)-1,2,3,4-四羥丁基)-1h-咪唑-2-基)乙酮肟的固體形式 |
TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
US8759364B2 (en) * | 2008-03-31 | 2014-06-24 | The Trustees Of Columbia University In The City Of New York | Methods of treating bone mass diseases |
TW201002698A (en) * | 2008-06-18 | 2010-01-16 | Lexicon Pharmaceuticals Inc | Methods of preparing imidazole-based bicyclic compounds |
AU2009271408A1 (en) * | 2008-06-18 | 2010-01-21 | Lexicon Pharmaceuticals, Inc. | Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl) -1H-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
HUE030424T2 (en) | 2008-07-23 | 2017-05-29 | Arena Pharm Inc | Substituted 1,2,3,4-tetrahydrocyclopenta [b] indol-3-ylacetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
SI2342205T1 (sl) | 2008-08-27 | 2016-09-30 | Arena Pharmaceuticals, Inc. | Substituirani triciklični kislinski derivati kot agonisti S1P1 receptorja, uporabni v zdravljenju avtoimunskih in vnetnih obolenj |
AR074062A1 (es) * | 2008-10-31 | 2010-12-22 | Lexicon Pharmaceuticals Inc | Agonistas del receptor s1p para el tratamiento de la malaria cerebral y forma farmaceutica |
AR074061A1 (es) * | 2008-10-31 | 2010-12-22 | Lexicon Pharmaceuticals Inc | Inhibidores de s1p liasa para el tratamiento de la malaria cerebral y formulacion farmaceutica |
US20110098482A1 (en) * | 2009-10-26 | 2011-04-28 | Wenxue Wu | Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone |
ES2937386T3 (es) | 2010-01-27 | 2023-03-28 | Arena Pharm Inc | Procesos para la preparación de ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclopenta[b]indol-3-il)acético y sales del mismo |
TW201132630A (en) | 2010-02-18 | 2011-10-01 | Daiichi Sankyo Co Ltd | Imidazole derivatives |
WO2011109471A1 (en) | 2010-03-03 | 2011-09-09 | Arena Pharmaceuticals, Inc. | Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
WO2012002274A1 (ja) | 2010-06-28 | 2012-01-05 | 第一三共株式会社 | 培養細胞を用いたs1pリアーゼ阻害剤のスクリーニング方法 |
US9120835B2 (en) | 2011-06-28 | 2015-09-01 | Daiichi Sankyo Company Limited | Phosphoric acid ester derivatives |
WO2013049272A2 (en) | 2011-09-29 | 2013-04-04 | Theraceutix, Llc | Composition and method for treatment of symptoms associated with various skin conditions |
TR201302590A2 (tr) * | 2013-03-04 | 2014-09-22 | S Gueniz Kuecuekguezel | Diflunisalden hareketle yeni bileşiklerin sentezi. |
EP3242666A1 (en) | 2015-01-06 | 2017-11-15 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
JP6838744B2 (ja) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ, インコーポレイテッド | S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩 |
KR20190116416A (ko) | 2017-02-16 | 2019-10-14 | 아레나 파마슈티칼스, 인크. | 원발 담즙성 담관염을 치료하기 위한 화합물 및 방법 |
CN110545848A (zh) | 2017-02-16 | 2019-12-06 | 艾尼纳制药公司 | 用于治疗具有肠外表现的炎症性肠病的化合物和方法 |
CN111032041A (zh) | 2017-05-16 | 2020-04-17 | 健艾仕生物医药有限公司 | 治疗类风湿关节炎的组合物和方法 |
EP3443986A1 (en) * | 2017-08-17 | 2019-02-20 | AC BioScience | Enhancement of chemotherapy efficiency by sphingosine-1-phosphate |
WO2020051378A1 (en) | 2018-09-06 | 2020-03-12 | Arena Pharmaceuticals, Inc. | Compounds useful in the treatment of autoimmune and inflammatory disorders |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE788548A (fr) * | 1971-09-10 | 1973-03-08 | Bayer Ag | Nouveaux acides 2-imidazolyl-carbonyl-benzoiques, leurs esters et leur sels, leur procede de preparation et leur application comme regulateursde croissance des vegetaux |
US4567194A (en) * | 1983-03-10 | 1986-01-28 | The Coca-Cola Company | 2-Acylimidazole compounds, their synthesis and use as medicinal agents |
US4614662A (en) * | 1985-08-26 | 1986-09-30 | D. D. Williamson & Co., Inc. | Fast cook-continuous process for production of ammonia caramel color |
US5561134A (en) * | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
JPH06510781A (ja) | 1991-09-26 | 1994-12-01 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ムピロシン関連の抗菌性、抗マイコプラスマ性化合物 |
GB9201391D0 (en) | 1992-01-22 | 1992-03-11 | Smithkline Beecham Plc | Method of treatment |
DE4205081A1 (de) | 1992-02-20 | 1993-08-26 | Bayer Ag | 1-acyloxy-2-azolyl-ethane |
US5324840A (en) * | 1992-06-11 | 1994-06-28 | Allergan, Inc. | Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
AU660852B2 (en) | 1992-11-25 | 1995-07-06 | Elan Pharma International Limited | Method of grinding pharmaceutical substances |
US5519040A (en) * | 1994-04-29 | 1996-05-21 | Allergan | Substituted thiazole sulfonamides as antiglaucoma agents |
TW384224B (en) | 1994-05-25 | 2000-03-11 | Nano Sys Llc | Method of preparing submicron particles of a therapeutic or diagnostic agent |
US5718388A (en) | 1994-05-25 | 1998-02-17 | Eastman Kodak | Continuous method of grinding pharmaceutical substances |
SE9401965D0 (sv) * | 1994-06-07 | 1994-06-07 | Astra Ab | New compounds |
US6420522B1 (en) * | 1995-06-05 | 2002-07-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
EP1125932A3 (en) * | 1994-07-27 | 2001-08-29 | G.D. Searle & Co. | Substituted thiazoles for the treatment of inflammation |
BR9509024A (pt) * | 1994-09-26 | 1997-09-30 | Shionogi & Co | Derivados de imidazol |
JPH08151386A (ja) | 1994-09-27 | 1996-06-11 | Takeda Chem Ind Ltd | 複素環エチルチオセフェム化合物、その製造法および抗菌組成物 |
US5662883A (en) | 1995-01-10 | 1997-09-02 | Nanosystems L.L.C. | Microprecipitation of micro-nanoparticulate pharmaceutical agents |
US5665331A (en) | 1995-01-10 | 1997-09-09 | Nanosystems L.L.C. | Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers |
US5534270A (en) | 1995-02-09 | 1996-07-09 | Nanosystems Llc | Method of preparing stable drug nanoparticles |
US5510118A (en) | 1995-02-14 | 1996-04-23 | Nanosystems Llc | Process for preparing therapeutic compositions containing nanoparticles |
US5543133A (en) | 1995-02-14 | 1996-08-06 | Nanosystems L.L.C. | Process of preparing x-ray contrast compositions containing nanoparticles |
US5718919A (en) | 1995-02-24 | 1998-02-17 | Nanosystems L.L.C. | Nanoparticles containing the R(-)enantiomer of ibuprofen |
US5834025A (en) | 1995-09-29 | 1998-11-10 | Nanosystems L.L.C. | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
FR2743366B1 (fr) * | 1996-01-10 | 1998-02-06 | Rhone Poulenc Rorer Sa | Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant |
ZA974811B (en) | 1996-05-31 | 1997-12-30 | Univ Wollongong | Novel therapeutic compounds. |
US6136566A (en) | 1996-10-04 | 2000-10-24 | Lexicon Graphics Incorporated | Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
US6139833A (en) | 1997-08-08 | 2000-10-31 | Lexicon Genetics Incorporated | Targeted gene discovery |
US6207371B1 (en) | 1996-10-04 | 2001-03-27 | Lexicon Genetics Incorporated | Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
US6423527B1 (en) * | 1997-09-29 | 2002-07-23 | Children's Hospital Medical Center Of Northern California | Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
US6098631A (en) * | 1998-01-21 | 2000-08-08 | The Regents Of The University Of Michigan | Compositions and methods for treating autoimmune disease |
US6180650B1 (en) * | 1999-04-23 | 2001-01-30 | Merck Frosst Canada & Co. | Heterosubstituted pyridine derivatives as PDE 4 inhibitors |
AU777594B2 (en) * | 1999-05-24 | 2004-10-21 | Mitsubishi Pharma Corporation | Phenoxypropylamine compounds |
JP4156807B2 (ja) | 1999-06-01 | 2008-09-24 | エラン ファーマ インターナショナル,リミティド | 小型ミル及びその方法 |
DE10025672A1 (de) | 2000-05-24 | 2001-11-29 | Henkel Kgaa | Mittel zum Färben von keratinhaltigen Fasern |
EP1363643A2 (en) * | 2000-12-22 | 2003-11-26 | Medlyte, Inc. | Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
DE10111936C1 (de) * | 2001-03-13 | 2002-10-02 | Wella Ag | N-Heteroarylmethyl-m-phenylendiamin-Derivate enthaltende Haarfärbemittel sowie neue N-Heteroarylmethyl-m-phenylendiamin-Derivate |
CA2449490C (en) | 2001-06-05 | 2010-10-05 | Elan Pharma International Limited | System and method for milling materials |
US6976647B2 (en) | 2001-06-05 | 2005-12-20 | Elan Pharma International, Limited | System and method for milling materials |
DE10130145A1 (de) * | 2001-06-22 | 2003-01-02 | Wella Ag | Kationische Farbstoffe, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Färbemittel |
ATE526319T1 (de) * | 2001-08-10 | 2011-10-15 | Nippon Chemiphar Co | Aktivator für den peroxisome proliferator- responsiven rezeptor delta |
AU2002323475B2 (en) * | 2001-09-13 | 2006-09-28 | Synta Pharmaceuticals Corp | 2-aroylimidazole compounds for treating cancer |
US6692960B2 (en) * | 2001-09-28 | 2004-02-17 | Isis Pharmaceuticals, Inc. | Antisense modulation of sphingosine-1-phosphate lyase expression |
DE60334924D1 (de) | 2002-09-11 | 2010-12-23 | Elan Pharma Int Ltd | Anoteilchengrösse |
WO2004071509A1 (ja) | 2003-02-12 | 2004-08-26 | Nippon Chemiphar Co., Ltd. | オリゴデンドロサイト分化促進剤 |
US20050042177A1 (en) | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
CA2550091A1 (en) * | 2003-12-19 | 2005-07-07 | Elixir Pharmaceuticals, Inc. | Methods of treating a disorder |
CA2553670A1 (en) * | 2004-01-29 | 2005-08-11 | Elixir Pharmaceuticals, Inc. | Anti-viral therapeutics |
GB0402653D0 (en) | 2004-02-06 | 2004-03-10 | Cyclacel Ltd | Compounds |
WO2005085241A1 (ja) * | 2004-03-05 | 2005-09-15 | Taisho Pharmaceutical Co., Ltd. | チアゾール誘導体 |
TW200848029A (en) | 2007-03-01 | 2008-12-16 | Lexicon Pharmaceuticals Inc | Heterocyclic compounds, compositions comprising them and methods of their use |
TWI412362B (zh) | 2007-04-12 | 2013-10-21 | Lexicon Pharmaceuticals Inc | (e)-1-(4-((1r,2s,3r)-1,2,3,4-四羥丁基)-1h-咪唑-2-基)乙酮肟的固體形式 |
TW200920355A (en) | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
-
2007
- 2007-01-25 US US11/698,253 patent/US7649098B2/en active Active
- 2007-02-21 EP EP20090003951 patent/EP2090334B1/en active Active
- 2007-02-21 ES ES07751414.9T patent/ES2456673T3/es active Active
- 2007-02-21 PT PT77514149T patent/PT2010501E/pt unknown
- 2007-02-21 PL PL07751414T patent/PL2010501T3/pl unknown
- 2007-02-21 DK DK07751414.9T patent/DK2010501T3/da active
- 2007-02-21 NZ NZ570308A patent/NZ570308A/en unknown
- 2007-02-21 KR KR1020087020596A patent/KR20080096570A/ko not_active Application Discontinuation
- 2007-02-21 EA EA200870292A patent/EA015783B1/ru not_active IP Right Cessation
- 2007-02-21 AU AU2007221265A patent/AU2007221265B2/en active Active
- 2007-02-21 BR BRPI0710076-0A patent/BRPI0710076A2/pt not_active Application Discontinuation
- 2007-02-21 JP JP2008556424A patent/JP5153655B2/ja active Active
- 2007-02-21 WO PCT/US2007/004648 patent/WO2007100617A2/en active Application Filing
- 2007-02-21 SG SG201101294-5A patent/SG170024A1/en unknown
- 2007-02-21 MX MX2008010772A patent/MX2008010772A/es active IP Right Grant
- 2007-02-21 CA CA2643021A patent/CA2643021C/en active Active
- 2007-02-21 EP EP07751414.9A patent/EP2010501B1/en active Active
-
2008
- 2008-08-07 ZA ZA2008/06842A patent/ZA200806842B/en unknown
- 2008-08-07 IL IL193297A patent/IL193297A/en active IP Right Grant
- 2008-08-21 EC EC2008008692A patent/ECSP088692A/es unknown
- 2008-09-22 NO NO20084024A patent/NO20084024L/no not_active Application Discontinuation
-
2009
- 2009-12-01 US US12/628,309 patent/US8093267B2/en active Active
-
2012
- 2012-01-04 US US13/343,073 patent/US8404732B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2010501T3 (da) | Imidazolbaserede forbindelser, sammensætninger omfattende disse og fremgangsmåder for deres anvendelse | |
BRPI0716325A2 (pt) | Composição antimicrobianas | |
DK2076260T3 (da) | N-methylaminomethyl-isoindol-forbindelser og sammensætninger, der indeholder disse, samt fremgangsmåder til deres anvendelse | |
BRPI0809573A8 (pt) | composição, e, método | |
FR2899479B1 (fr) | Composition cicatrisante | |
DK2069352T3 (da) | Bestemte kemiske enheder, sammensætninger og fremgangsmåder | |
DK2087002T3 (da) | Sammensætninger og fremgangsmåder til binding af sphingosin-1-phosphat | |
ITBO20050495A1 (it) | Elettrocatetere esogageo | |
BRPI0807908A2 (pt) | Melhoramentos em composições medicinais. | |
AR062844A1 (es) | Composicion pesticida | |
DE602005005527D1 (de) | Verschlussdüse | |
BRPI0813775A2 (pt) | Composição | |
ATE528048T1 (de) | Schweisshemmende/desodorierende zusammensetzung | |
NO20055686D0 (no) | Sammensetning | |
BRPI0810525A2 (pt) | Composições e métodos para a profilaxia e tratamento de dependência química | |
DK1929865T3 (da) | Cyclopropensammensætninger | |
DK2079485T3 (da) | Phenylpropionamidforbindelser og anvendelsen deraf | |
BRPI0814167A2 (pt) | Composição, e, método | |
BRPI0810557A2 (pt) | composição | |
BRPI0811274A2 (pt) | Composição | |
DE602005019525D1 (de) | Verschlussdüse | |
DE502006006067D1 (de) | Ng | |
BRPI0814230A2 (pt) | Composição herbicida | |
BRPI0811178A2 (pt) | Composição herbicida | |
BRPI0814748A2 (pt) | Compostos de alditóis substituídos, composições e métodos |